Home - Products - Others - Other Targets - Furobufen

Furobufen

CAS No. 38873-55-1

Furobufen( —— )

Catalog No. M33363 CAS No. 38873-55-1

Furobufen is a compound with anti-inflammatory and analgesic activity and can be used in the study of arthritis.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	73	Get Quote
5MG	117	Get Quote
10MG	178	Get Quote
25MG	288	Get Quote
50MG	426	Get Quote
100MG	611	Get Quote
500MG	1287	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Furobufen
Note

Research use only, not for human use.
Brief Description

Furobufen is a compound with anti-inflammatory and analgesic activity and can be used in the study of arthritis.
Description

Furobufen, an anti-inflammatory agent, produces antiarthritic, antipyretic effects. Furobufen has an analgesic effect in inflamed tissue.
In Vitro

——
In Vivo

Furobufen (po; 10, 30, 90 mg/kg; once daily; 7 days) produces a dose-related inhibition of the paw edema produced by carrageenan in male rats weighing 180-200 g.
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

38873-55-1
Formula Weight

268.26
Molecular Formula

C16H12O4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (372.77 mM; Ultrasonic )
SMILES

OC(=O)CCC(=O)c1ccc2oc3ccccc3c2c1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Martel RR, et al. Anti-inflammatory properties of furobufen. Can J Physiol Pharmacol. 1974 Jun;52(3):669-73.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

RS 42358-197

RS 42358-197 is the S-isomer of RS-42358, which is the novel 5-HT3 receptor antagonist.
DL-Homocysteic acid

DL-Homocysteic acid is a useful organic compound for research related to life sciences.
Sibeprenlimab

Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody that inhibits APRIL and may be investigated for the prevention and treatment of kidney disease (IgAN).

Sign In Join Free